Tongaat Hulett Limited Stocks

ZAC 0Last Updated 23.03.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

ZAC 321532.93779

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
ZAC 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Tongaat Hulett Limited operates as an agriculture and agri-processing company in Zimbabwe, Mozambique, South Africa, Other SADC, North America, Europe and Middle East, and the Asia-Pacific. It produces and sells a range of refined sugarcane and maize based carbohydrate products; sweeteners; energy and supplementary feeds to the livestock farming community under the Voermol brand using bagasse and molasses; and corn starch, glucose, and other related products under the Amryal, Hydex, and Vaalgold Gluten 60 brands. The company also provides white and brown sugar products under the Huletts, SunSweet, and Blue Crystal brands. In addition, it engages in the land conversion and development activities. Further, the company is involved in the production of ethanol; and generation of renewable electricity from bagasse. Tongaat Hulett Limited was founded in 1875 and is based in Tongaat, South Africa.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is 'expensive' on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks